Corvex (NASDAQ:MOVE – Get Free Report) will likely be releasing its Q3 2026 results before the market opens on Thursday, November 12th. Analysts expect Corvex to post earnings of ($0.09) per share and revenue of $5.54 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 12, 2026 at 8:30 AM ET.
Corvex (NASDAQ:MOVE – Get Free Report) last released its quarterly earnings data on Friday, August 14th. The AI infrastructure company reported ($5.12) EPS for the quarter, missing the consensus estimate of ($3.17) by ($1.95). The firm had revenue of $3.80 million during the quarter, compared to the consensus estimate of $6.71 million. On average, analysts expect Corvex to post ($0.53) EPS for the current fiscal year and ($0.70) EPS for the next fiscal year.
Corvex Price Performance
Shares of MOVE opened at $4.96 on Wednesday. The company has a market cap of $156.50 million, a price-to-earnings ratio of -0.26 and a beta of 0.93. Corvex has a 1-year low of $4.34 and a 1-year high of $26.72. The company’s fifty day simple moving average is $9.79 and its 200 day simple moving average is $13.85. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 4.28.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the stock. Chardan Capital set a $18.75 price objective on shares of Corvex and gave the company a “buy” rating in a research report on Wednesday, September 16th. Weiss Ratings downgraded Corvex from a “sell (d)” rating to a “sell (e)” rating in a research report on Thursday, October 8th. Finally, Zacks Research upgraded Corvex to a “hold” rating in a research note on Friday, September 18th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Corvex currently has a consensus rating of “Hold” and an average target price of $18.75.
Read Our Latest Stock Analysis on MOVE
About Corvex
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
Featured Stories
- Five stocks we like better than Corvex
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Corvex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corvex and related companies with MarketBeat.com's FREE daily email newsletter.
